Disabled people with permanent, progressive conditions are being repeatedly reassessed for Personal Independence Payment (PIP) — a process that produces little useful information, according to a May 2026 analysis by Z2K, published on 20 June 2026. This continues even as the government has begun protecting some of the most severely disabled from similar assessments for Universal Credit, creating an obvious tension in how welfare policy treats people whose conditions will never improve.

The government announced last year that more than 200,000 people with the most severe and lifelong conditions would be shielded from future reassessment under Universal Credit. Yet people with conditions like motor neurone disease or progressive multiple sclerosis are still cycled through PIP reassessments on regular schedules, as if their disabilities might improve. Z2K's research, building on earlier work documenting the anxiety and burden these assessments place on claimants, now argues for a condition-based exemption: a system where certain diagnoses automatically qualify for permanent status rather than periodic review.

The government's own policy direction points toward this same solution, if slowly. Regulations introduced in April 2026 created a temporary window of protection for people with lifelong or deteriorating conditions. The Pathways to Work Green Paper acknowledged the need to streamline assessments for severe, permanent disabilities. Yet these are partial measures—acknowledgment without full delivery.

Why the System Works Against Permanent Conditions

PIP was built around the assumption that benefit needs fluctuate. For working-age people whose abilities might genuinely change—recovery, adaptation, return to work—reassessment on a schedule makes sense. The architecture breaks down when applied to people whose medical trajectory runs the opposite direction: toward progressive deterioration, not improvement.

Yet the same reassessment cycle applies to both groups. Z2K's earlier report, Ending the Culture of Fear, documented the broader problems: the anxiety claimants experience, the burden of re-evidencing unchanged needs, and the gap between what medical assessments show and what welfare assessments conclude.

The practical impact on individuals is substantial. Each reassessment requires people to re-prove disabilities that haven't changed clinically. When reassessments fail or reduce awards, claimants typically appeal—and tribunal success rates have run well above 50 percent in recent years, suggesting the system is systematically miscalibrating rather than making isolated errors.

Why This Hasn't Been Fixed Yet

Z2K raised this exact concern in response to the 2021 Health and Disability Green Paper. That it's still being argued five years later tells you something about the pace of structural change in the welfare system.

Part of the delay is practical. Defining which conditions should qualify for permanent exemption requires clinical expertise, legal precision, and DWP capacity to implement—none of which moves quickly. There's also a fiscal consideration: any categorical exemption reduces the department's ability to conduct periodic reviews, which ministers have historically defended as a safeguard against incorrect long-term awards. Protecting the most severely disabled has had to be negotiated alongside broader cost-containment goals.

It's also worth noting that the 200,000-figure announced by the government applies to Universal Credit specifically. PIP operates under a separate assessment framework—the benefit that covers disability-related extra costs, separate from basic income support. The exemption Z2K advocates would target that regime directly.

The remaining question is whether the Pathways to Work reforms, as they're being legislated, will actually close the gap between what the government says it intends and what Z2K's data shows is happening on the ground. The regulatory framework is shifting, but the test is whether it shifts with enough precision to match exemptions to actual conditions rather than administrative categories that still lag clinical reality.